Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance
- 1 November 2003
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 64 (87), S78-S86
- https://doi.org/10.1046/j.1523-1755.64.s87.12.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- White blood cells as a novel mortality predictor in haemodialysis patientsNephrology Dialysis Transplantation, 2003
- Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patientsNephrology Dialysis Transplantation, 2000
- The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis studyKidney International, 2000
- Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patientsAmerican Journal of Kidney Diseases, 1999
- The acute phase response and the hematopoietic system: the role of cytokinesCritical Reviews in Oncology/Hematology, 1995